Your browser is no longer supported. Please, upgrade your browser.
Settings
LCI Lannett Company, Inc. daily Stock Chart
LCI [NYSE]
Lannett Company, Inc.
Index- P/E- EPS (ttm)-0.87 Insider Own7.90% Shs Outstand38.75M Perf Week-3.33%
Market Cap226.42M Forward P/E6.26 EPS next Y0.93 Insider Trans-1.98% Shs Float30.64M Perf Month-2.35%
Income-33.40M PEG- EPS next Q0.10 Inst Own93.20% Short Float32.03% Perf Quarter-18.40%
Sales545.70M P/S0.41 EPS this Y88.00% Inst Trans-1.13% Short Ratio15.42 Perf Half Y-18.40%
Book/sh7.82 P/B0.74 EPS next Y45.00% ROA-2.90% Target Price7.75 Perf Year-58.20%
Cash/sh3.70 P/C1.57 EPS next 5Y15.00% ROE-10.60% 52W Range4.89 - 14.72 Perf YTD-34.13%
Dividend- P/FCF2.32 EPS past 5Y-17.20% ROI3.30% 52W High-60.53% Beta1.45
Dividend %- Quick Ratio1.40 Sales past 5Y6.10% Gross Margin30.30% 52W Low18.81% ATR0.29
Employees954 Current Ratio2.10 Sales Q/Q3.10% Oper. Margin3.20% RSI (14)50.62 Volatility4.90% 5.20%
OptionableYes Debt/Eq2.25 EPS Q/Q-25.20% Profit Margin-6.10% Rel Volume0.59 Prev Close6.08
ShortableYes LT Debt/Eq1.96 EarningsAug 26 AMC Payout- Avg Volume636.27K Price5.81
Recom3.00 SMA202.67% SMA50-0.64% SMA200-22.87% Volume376,471 Change-4.44%
Mar-20-19Initiated SunTrust Hold
Aug-20-18Downgrade ROTH Capital Buy → Neutral
Aug-20-18Downgrade Raymond James Outperform → Mkt Perform
Jan-24-18Initiated Goldman Neutral
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Aug-27-20 06:07AM  
Aug-26-20 08:30PM  
05:14PM  
04:15PM  
Aug-25-20 10:14AM  
Aug-19-20 06:52AM  
Aug-17-20 04:30PM  
06:52AM  
Aug-03-20 06:53AM  
Jul-27-20 06:52AM  
Jul-23-20 06:52AM  
Jul-16-20 12:14PM  
06:55AM  
Jul-13-20 07:34AM  
06:52AM  
Jun-22-20 03:04PM  
Jun-11-20 06:52AM  
May-25-20 10:37AM  
May-08-20 07:28AM  
May-07-20 01:07PM  
03:30AM  
May-06-20 08:15PM  
04:15PM  
Apr-29-20 06:52AM  
Apr-28-20 08:22AM  
Apr-27-20 12:31PM  
Apr-08-20 06:52AM  
Apr-07-20 12:57PM  
Mar-31-20 06:54AM  
Mar-09-20 06:52AM  
Feb-28-20 10:27AM  
Feb-12-20 12:16AM  
Feb-05-20 06:05PM  
04:15PM  
Jan-30-20 06:52AM  
Jan-29-20 12:31PM  
Jan-14-20 01:03PM  
12:04PM  
Jan-13-20 11:51AM  
06:52AM  
Jan-06-20 06:52AM  
Dec-23-19 06:52AM  
Dec-13-19 05:45PM  
Dec-12-19 12:29PM  
08:48AM  
06:57AM  
Dec-04-19 08:41AM  
08:37AM  
06:52AM  
Nov-26-19 12:31PM  
Nov-23-19 01:08AM  
Nov-18-19 11:42AM  
Nov-06-19 06:05PM  
04:15PM  
03:14PM  
11:10AM  
10:41AM  
Nov-05-19 11:17AM  
10:42AM  
Oct-31-19 05:45PM  
Oct-30-19 10:34AM  
06:52AM  
Oct-25-19 10:51AM  
Oct-24-19 05:50PM  
Oct-23-19 09:30AM  
Oct-18-19 05:45PM  
11:22AM  
Oct-17-19 08:03AM  
Oct-08-19 05:50PM  
Oct-07-19 09:30AM  
Oct-04-19 10:00PM  
Oct-01-19 09:13AM  
06:52AM  
Sep-27-19 04:15PM  
Sep-25-19 09:20AM  
07:40AM  
Sep-24-19 04:15PM  
Sep-20-19 10:00AM  
Sep-19-19 02:38PM  
10:42AM  
Sep-16-19 07:42AM  
Sep-13-19 08:24AM  
Sep-11-19 10:13AM  
Sep-09-19 10:36AM  
07:31AM  
Sep-04-19 09:15AM  
Sep-03-19 10:47AM  
Aug-29-19 11:59AM  
09:50AM  
08:44AM  
Aug-28-19 12:51PM  
12:36PM  
12:32PM  
09:50AM  
07:06AM  
06:52AM  
04:18AM  
Aug-27-19 10:23PM  
09:30PM  
05:45PM  
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Abt JohnChief Quality and OperationsSep 03Sale5.271,0005,27086,015Sep 04 03:24 PM
Crew Timothy CChief Executive OfficerSep 01Buy5.103,00015,300399,232Sep 02 04:18 PM
Drabik David ADirectorMay 19Sale7.3737,220274,31145,972May 21 04:19 PM
Taveira PaulDirectorMay 19Sale7.2230,000216,60051,415May 21 04:17 PM
Crew Timothy CChief Executive OfficerMay 12Buy7.573,00022,710190,738May 13 05:10 PM
Crew Timothy CChief Executive OfficerNov 11Buy8.992,00017,980186,567Nov 12 04:39 PM